Literature DB >> 28968703

Improved flare and remission pattern in rheumatoid arthritis over recent decades: a population-based study.

Shafay Raheel1, Eric L Matteson1,2, Cynthia S Crowson1,3, Elena Myasoedova1.   

Abstract

Objective: To assess trends in the occurrence of flares and remission in RA over recent decades.
Methods: A retrospective medical records review of each clinical visit was performed in a population-based cohort of patients with RA (age ⩾30 years; 1987 ACR criteria met in 1988-2007) to estimate flare and remission status. RA flare was defined as any worsening of RA activity leading to an initiation, change or increase of therapy (OMERACT 9). The primary definition for remission required the absence of RA disease activity (i.e. tender joint count 0, swollen joint count 0 and ESR ⩽10 mm/h) (OMERACT 7). All subjects were followed until death, migration or 1 July 2012.
Results: The study included 650 RA patients (mean age 55.8 years; 69% female) with a mean follow up of 10.3 years. Patients were flaring at 2887 (17%) visits. There was a significant decline in the RA flare rate across disease duration (P < 0.001), predominantly in the first 5 years after diagnosis of RA. Patients diagnosed with RA in more recent years experienced fewer flares during first few years of RA (P < 0.001). There was no difference between the sexes in trends of flare rates over time (P = 0.42) Current smokers had higher flare rates than non-smokers (P = 0.047) and former smokers were not different from non-smokers (P = 0.87).
Conclusion: Patients diagnosed in more recent years have lower flare rates than those diagnosed in prior decades. Flare rates declined fastest in the first 5 years of disease and tended to be stable thereafter. Current smoking was associated with an adverse flare profile.
© The Author 2017. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com

Entities:  

Keywords:  flare; rheumatoid arthritis; trends

Mesh:

Substances:

Year:  2017        PMID: 28968703      PMCID: PMC5850789          DOI: 10.1093/rheumatology/kex352

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  27 in total

Review 1.  Rochester Epidemiology Project: a unique resource for research in the rheumatic diseases.

Authors:  Hilal Maradit Kremers; Cynthia S Crowson; Sherine E Gabriel
Journal:  Rheum Dis Clin North Am       Date:  2004-11       Impact factor: 2.670

Review 2.  Impact of Obesity on Remission and Disease Activity in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis.

Authors:  Yang Liu; Glen S Hazlewood; Gilaad G Kaplan; Bertus Eksteen; Cheryl Barnabe
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-12-31       Impact factor: 4.794

Review 3.  Predictors for remission in rheumatoid arthritis patients: A systematic review.

Authors:  Wanruchada Katchamart; Sindhu Johnson; Hsing-Ju Lucy Lin; Veerapong Phumethum; Carine Salliot; Claire Bombardier
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-08       Impact factor: 4.794

4.  Incidence of extraarticular rheumatoid arthritis in Olmsted County, Minnesota, in 1995-2007 versus 1985-1994: a population-based study.

Authors:  Elena Myasoedova; Cynthia S Crowson; Carl Turesson; Sherine E Gabriel; Eric L Matteson
Journal:  J Rheumatol       Date:  2011-04-01       Impact factor: 4.666

5.  Sustained clinical remission in rheumatoid arthritis: prevalence and prognostic factors in an inception cohort of patients treated with conventional DMARDS.

Authors:  Keeranur Jayakumar; Sam Norton; Josh Dixey; David James; Andrew Gough; Peter Williams; Peter Prouse; Adam Young
Journal:  Rheumatology (Oxford)       Date:  2011-11-16       Impact factor: 7.580

6.  Effect of Smoking on Remission Proportions Differs Between Male and Female Patients with Rheumatoid Arthritis: A Study Based on the IORRA Survey.

Authors:  Yasushi Inoue; Ayako Nakajima; Eiichi Tanaka; Eisuke Inoue; Akiko Kobayashi; Daisuke Hoshi; Naoki Sugimoto; Yohei Seto; Atsuo Taniguchi; Shigeki Momohara; Hisashi Yamanaka
Journal:  J Rheumatol       Date:  2015-03-15       Impact factor: 4.666

7.  Efficient management of rheumatoid arthritis significantly reduces long-term functional disability.

Authors:  E Tanaka; A Mannalithara; E Inoue; M Hara; T Tomatsu; N Kamatani; G Singh; H Yamanaka
Journal:  Ann Rheum Dis       Date:  2007-10-30       Impact factor: 19.103

8.  Incidence of clinically important 10-year health status and disease activity levels in population-based cohorts with rheumatoid arthritis.

Authors:  Sigrid Odegård; Tore K Kvien; Till Uhlig
Journal:  J Rheumatol       Date:  2007-11-15       Impact factor: 4.666

9.  Developing a construct to evaluate flares in rheumatoid arthritis: a conceptual report of the OMERACT RA Flare Definition Working Group.

Authors:  Rieke Alten; Christof Pohl; Ernest H Choy; Robin Christensen; Daniel E Furst; Sarah E Hewlett; Amye Leong; James E May; Tessa C Sanderson; Vibeke Strand; Thasia G Woodworth; Clifton O Bingham
Journal:  J Rheumatol       Date:  2011-08       Impact factor: 4.666

10.  Disease flares in rheumatoid arthritis are associated with joint damage progression and disability: 10-year results from the BeSt study.

Authors:  Iris M Markusse; Linda Dirven; Andreas H Gerards; Johannes H L M van Groenendael; H Karel Ronday; Pit J S M Kerstens; Willem F Lems; Tom W J Huizinga; Cornelia F Allaart
Journal:  Arthritis Res Ther       Date:  2015-08-31       Impact factor: 5.156

View more
  4 in total

1.  The point of no return? Functional disability transitions in patients with and without rheumatoid arthritis: A population-based cohort study.

Authors:  Elena Myasoedova; John M Davis; Vanessa L Kronzer; Rachel E Giblon; Elizabeth J Atkinson; Nathan K LeBrasseur; Cynthia S Crowson
Journal:  Semin Arthritis Rheum       Date:  2021-12-31       Impact factor: 5.431

2.  Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis: a systematic review and economic evaluation.

Authors:  Irina A Tikhonova; Huiqin Yang; Segun Bello; Andrew Salmon; Sophie Robinson; Mohsen Rezaei Hemami; Sophie Dodman; Andriy Kharechko; Richard C Haigh; Meghna Jani; Timothy J McDonald; Martin Hoyle
Journal:  Health Technol Assess       Date:  2021-02       Impact factor: 4.014

3.  Antibiotic treatment and flares of rheumatoid arthritis: a self-controlled case series study analysis using CPRD GOLD.

Authors:  Navraj S Nagra; Danielle E Robinson; Ian Douglas; Antonella Delmestri; Stephanie G Dakin; Sarah J B Snelling; Andrew J Carr; Daniel Prieto-Alhambra
Journal:  Sci Rep       Date:  2019-06-20       Impact factor: 4.379

4.  Predictors of flare in rheumatoid arthritis patients with persistent clinical remission/low disease activity: Data from the TARAC cohort.

Authors:  Sumapa Chaiamnuay; Srisakul Jiemjit; Wipatcharin Songdechaphipat; Pongthorn Narongroeknawin; Rattapol Pakchotanon; Paijit Asavatanabodee
Journal:  Medicine (Baltimore)       Date:  2022-08-12       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.